Evaluation of the effect of statin therapy on airway inflammation and clinical outcome of moderate and severe bronchial asthma

Background Epidemiological data have linked statin use with improvements in lung health and asthma-related hospitalizations and/or emergency room visits. Aim The aim was to evaluate the effect of statin therapy on airway inflammation and clinical outcome in moderate and severe asthma. Patients and m...

Full description

Bibliographic Details
Main Authors: Eman S Nageeb, Ahmed M Abumossalam, Eman O Arram, Mohammad E Aboshehata
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2019;volume=68;issue=3;spage=328;epage=337;aulast=Nageeb
_version_ 1811285993160966144
author Eman S Nageeb
Ahmed M Abumossalam
Eman O Arram
Mohammad E Aboshehata
author_facet Eman S Nageeb
Ahmed M Abumossalam
Eman O Arram
Mohammad E Aboshehata
author_sort Eman S Nageeb
collection DOAJ
description Background Epidemiological data have linked statin use with improvements in lung health and asthma-related hospitalizations and/or emergency room visits. Aim The aim was to evaluate the effect of statin therapy on airway inflammation and clinical outcome in moderate and severe asthma. Patients and methods This study was conducted on 61 cases, but only 40 cases completed the study. Patients were recruited from outpatient clinic and general ward of Thoracic Medicine Department of Mansoura University Hospitals from May 2015 to June 2016. They were categorized into statin group, which included 20 asthmatic cases that received statin (atorvastatin with a dose of 20 mg daily for 3 months), serving as the study group, which was further subdivided into two subgroups: moderate and severe subgroups, and nonstatin group, which included 20 asthmatics cases that did not receive statin, serving as a control group, and they were further subdivided into two subgroups: moderate and severe subgroups. Results Using clinical, laboratory, functional and radiological score (CLFR) score at beginning and at the end of 3 months, we found that there was a significant difference in moderate cases in statin group (P pre-post=0.01FNx01) against moderate cases in nonstatin group (P pre-post=0.303). Moreover, a significant difference in CLFR score was found in severe cases in statin group (P pre-post=0.025FNx01) against severe cases in nonstatin group (P pre-post=0.136). Conclusion Statins have significant effect on inflammatory markers and bronchial asthma symptoms owing to their anti-inflammatory effects; therefore, statins may play a role in bronchial asthma management and could be used as an add-on therapy.
first_indexed 2024-04-13T02:53:09Z
format Article
id doaj.art-4e7316cb36d646fabe2e54a05b2f7260
institution Directory Open Access Journal
issn 0422-7638
2090-9950
language English
last_indexed 2024-04-13T02:53:09Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Egyptian Journal of Chest Disease and Tuberculosis
spelling doaj.art-4e7316cb36d646fabe2e54a05b2f72602022-12-22T03:05:48ZengWolters Kluwer Medknow PublicationsEgyptian Journal of Chest Disease and Tuberculosis0422-76382090-99502019-01-0168332833710.4103/ejcdt.ejcdt_175_18Evaluation of the effect of statin therapy on airway inflammation and clinical outcome of moderate and severe bronchial asthmaEman S NageebAhmed M AbumossalamEman O ArramMohammad E AboshehataBackground Epidemiological data have linked statin use with improvements in lung health and asthma-related hospitalizations and/or emergency room visits. Aim The aim was to evaluate the effect of statin therapy on airway inflammation and clinical outcome in moderate and severe asthma. Patients and methods This study was conducted on 61 cases, but only 40 cases completed the study. Patients were recruited from outpatient clinic and general ward of Thoracic Medicine Department of Mansoura University Hospitals from May 2015 to June 2016. They were categorized into statin group, which included 20 asthmatic cases that received statin (atorvastatin with a dose of 20 mg daily for 3 months), serving as the study group, which was further subdivided into two subgroups: moderate and severe subgroups, and nonstatin group, which included 20 asthmatics cases that did not receive statin, serving as a control group, and they were further subdivided into two subgroups: moderate and severe subgroups. Results Using clinical, laboratory, functional and radiological score (CLFR) score at beginning and at the end of 3 months, we found that there was a significant difference in moderate cases in statin group (P pre-post=0.01FNx01) against moderate cases in nonstatin group (P pre-post=0.303). Moreover, a significant difference in CLFR score was found in severe cases in statin group (P pre-post=0.025FNx01) against severe cases in nonstatin group (P pre-post=0.136). Conclusion Statins have significant effect on inflammatory markers and bronchial asthma symptoms owing to their anti-inflammatory effects; therefore, statins may play a role in bronchial asthma management and could be used as an add-on therapy.http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2019;volume=68;issue=3;spage=328;epage=337;aulast=Nageebairway inflammationCFLR scoresevere asthmastatin therapy
spellingShingle Eman S Nageeb
Ahmed M Abumossalam
Eman O Arram
Mohammad E Aboshehata
Evaluation of the effect of statin therapy on airway inflammation and clinical outcome of moderate and severe bronchial asthma
Egyptian Journal of Chest Disease and Tuberculosis
airway inflammation
CFLR score
severe asthma
statin therapy
title Evaluation of the effect of statin therapy on airway inflammation and clinical outcome of moderate and severe bronchial asthma
title_full Evaluation of the effect of statin therapy on airway inflammation and clinical outcome of moderate and severe bronchial asthma
title_fullStr Evaluation of the effect of statin therapy on airway inflammation and clinical outcome of moderate and severe bronchial asthma
title_full_unstemmed Evaluation of the effect of statin therapy on airway inflammation and clinical outcome of moderate and severe bronchial asthma
title_short Evaluation of the effect of statin therapy on airway inflammation and clinical outcome of moderate and severe bronchial asthma
title_sort evaluation of the effect of statin therapy on airway inflammation and clinical outcome of moderate and severe bronchial asthma
topic airway inflammation
CFLR score
severe asthma
statin therapy
url http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2019;volume=68;issue=3;spage=328;epage=337;aulast=Nageeb
work_keys_str_mv AT emansnageeb evaluationoftheeffectofstatintherapyonairwayinflammationandclinicaloutcomeofmoderateandseverebronchialasthma
AT ahmedmabumossalam evaluationoftheeffectofstatintherapyonairwayinflammationandclinicaloutcomeofmoderateandseverebronchialasthma
AT emanoarram evaluationoftheeffectofstatintherapyonairwayinflammationandclinicaloutcomeofmoderateandseverebronchialasthma
AT mohammadeaboshehata evaluationoftheeffectofstatintherapyonairwayinflammationandclinicaloutcomeofmoderateandseverebronchialasthma